Table 2. Currently available glucagon-like peptide-1 receptor agonists in Korea.

	Compound	Brand name	Dosing
Short-acting	Exenatde	Byetta	5–10 µg SC twice daily prior to meals
	Lixisenatide	Lyxumia	10 µg SC once daily, in the hour before the same meal for 14 days → a fixed maintenance dose of 20 µg once daily
Long-acting	Liraglutide	Victoza	0.6–1.8 mg SC once daily without regard to meals
		Saxenda	BMI ≥30 kg/m2
			BMI 27–30 kg/m2+prediabetes, T2DM, HTN, or dyslipidemia 3 mg daily for 12 weeks
	Dulaglutide	Trulicity	0.75–1.5 mg SC once weekly without regard to meals

Modified from Korean Diabetes Association [37].

SC, subcutaneous; BMI, body mass index; T2DM, type 2 diabetes mellitus; HTN, hypertension.